SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty Cassava Sciences and its executives face a $40 million SEC settlement over ...
Some results have been hidden because they may be inaccessible to you